Clinical Trial

Dexmedetomidine-Esketamine Combination and Sleep Disturbances After Major Noncardiac Surgery

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Sleep disturbances are common early after major surgery, and are associated with delayed recovery. A previous study showed that dexmedetomidine-esketamine combination as a supplement to patient-controlled intravenous analgesia improved postoperative analgesia and subjective sleep quality in patients after scoliosis correction surgery. The purpose of this trial is to test the hypothesis that dexmedetomidine-esketamine combination used as a supplement during general anesthesia and postoperative intravenous analgesia may reduce sleep disturbances in adult after major noncardiac surgery.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-02-28; most recent amendment 2025-03-18.
Status change: Not Yet Recruiting → Recruiting 2025-03-18
Trial Details
NCT Number NCT06859892
Lead Sponsor Peking University First Hospital
Conditions Adults, Major Noncardiac Surgery, Dexmedetomidine, Esketamine, Postoperative Sleep Disturbances
Enrollment 476 participants
Start Date 2025-03-18
Primary Completion 2026-11 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-19